BioSpace News Archive

The first completed bio-banks will be used to develop more cost-effective, safe and efficacious cancer treatments

AMN Healthcare Services, Inc. will host a conference call to discuss its fourth quarter and full year 2018 financial results on Thursday, February 14, 2019 at 5:00 p.m. Eastern Time.

Intabio, Inc. today announced it will showcase the latest advances in high-resolution imaged capillary isoelectric focusing (cIEF) coupled to electrospray ionization mass spectrometry (ESI-MS) at January’s WCBP Conference in Washington, D.C.

TWi Biotechnology Inc. announced today that it has completed patient enrollment in its Phase 2 clinical trial

Branning Brings Expertise in Leading Change Management Across Complex and Rapidly Evolving Organizations

ACell, Inc. announced their participation in Arab Health 2019, being held January 28-31 in Dubai. ACell will be part of the State of Maryland Delegation at the USA Partnership Pavilion.

Award-winning provider of non-medical home care earns ranking for eighth straight year

Acquisition increases the Company’s capacity to supply branded cannabis products

Agreement brings innovative CytoSorb® therapy to Korea and Mexico and sets the stage for future growth [22-January-2019] MONMOUTH JUNCTION, N.J. , Jan. 22, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and ca

Neovasc Inc. today announced that, pursuant to a settlement reached with Edwards Lifesciences PVT, Inc. and Edwards Lifesciences (Canada) Inc. (collectively, “Edwards”), the patent infringement action that Edwards had previously commenced in the Federal Court of Canada against Neovasc, Boston Scientific and Livanova, will be dismissed on a no-costs basis.